MedElevator Войти в исследования
← Поиск публикаций
Медицинская библиотека · Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2006

[Inhibitory effect of Biejiajianwan pills on tumor growth and proliferating cell nuclear antigen expression in mice bearing H22 cell-induced tumor].

Zhang Xu-hui, Chen Da-li, Luo Rong-cheng

Аннотация на английскомСтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

OBJECTIVE

To study the anti-tumor effect of Biejiajianwan pills and explore its mechanism.

METHODS

Mice bearing neoplasm induced by H22 cell inoculation were randomized into 4 groups, namely the negative control group, positive control group (with cyclophosphamide treatment), and high- and low-dose Biejiajianwan pill group. The tumor-bearing mice received corresponding treatments for 15 consecutive days, after which their thymuses and spleens were isolated and weighed to calculate the thymus and spleen indices. The tumor mass was also weighed and the tumor inhibition rate calculated. Immunohistochemistry was performed to evaluate the expression intensity of proliferating cell nuclear antigen (PCNA) in the tumor tissue.

RESULTS

The pills significantly inhibited the growth of the implanted tumor and reduced the expression of PCNA in the tumor.

CONCLUSION

One of the possible mechanisms of the anti-tumor effects of Biejiajian pills might be associated with the inhibition of PCNA expression in the tumor.

Для цитирования: Zhang Xu-hui, Chen Da-li, Luo Rong-cheng. [Inhibitory effect of Biejiajianwan pills on tumor growth and proliferating cell nuclear antigen expression in mice bearing H22 cell-induced tumor].. Nan fang yi ke da xue xue bao = Journal of Southern Medical University. 2006.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.